IPV 疫苗市場：按疫苗品牌、分銷管道、地區 - 市場規模、佔有率、前景、機會分析，2024-2031 年

預計2024年全球IPV疫苗市場規模為1.996億美元，預測期間（2024-2031年）年複合成長率為8.5%。

2024 年全球 IPV 疫苗市場規模（百萬美元），按地區分類

去活化脊髓灰質炎疫苗（IPV）也稱為索爾克疫苗。脊髓灰質炎疫苗有兩種：去活化脊髓灰質炎疫苗和口服脊髓灰質炎疫苗。 IPV 疫苗主要注射到手臂和腿部。

對雞蛋或鏈黴素等藥物過敏的人不應接受 IPV 注射。只有當接種疫苗的人正在接受長期類固醇治療、患有癌症、正在接受化療或家中有未免疫的成年人時，才會接種 IPV。

預計 2024 年全球 IPV 疫苗市值為 1.996 億美元，到 2031 年將擴大到 3.524 億美元，預測期內年複合成長率為 8.5%。

市場動態

為了預防脊髓灰質炎的爆發，各國政府已採取舉措提高人們對疫苗接種的認知。公共推出了有益的免疫計劃，為窮人提供疫苗接種，預計這為全球去活化脊髓灰質炎疫苗市場（IPV）的成長創造了非常有利的環境。例如，2019年9月，加納衛生服務局（GHS）啟動了一系列脊髓灰質炎疫苗接種/免疫宣傳活動，以防止病毒在高風險地區傳播。脊髓灰質炎疫苗免疫宣傳活動將使用去活化脊髓灰質炎疫苗（IPV）為加納所有地區2016年1月至2018年6月期間出生的所有兒童進行免疫接種。

本研究的主要特點

• 本報告詳細分析了以2023年為基準年的預測期（2024-2031）全球IPV疫苗市場規模和年複合成長率（CAGR%）。
• 它闡明了不同細分市場的潛在商機，並描述了該市場有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
• 它根據公司簡介、業績、產品系列、市場影響、分銷策略、關鍵發展、策略和未來計劃等參數，介紹了全球 IPV 疫苗市場的主要企業。
• 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
• IPV 疫苗市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進入者和財務分析師。
• 透過用於分析全球 IPV 疫苗市場的各種策略矩陣，將有助於相關人員做出決策。

目錄

第1章 研究目的與前提

• 研究目標
• 先決條件

第2章 市場概況

• 報告說明
  • 市場定義和範圍
• 執行摘要
• 市場機會藍圖

第 3 章主要見解

• 市場動態
  • 促進因素
  • 抑制因素
  • 機會
• 影響分析
• PEST分析
• 波特分析
• 公司市場佔有率分析
• 進出口分析
• 監管場景
• 價格分析
• COVID-19 影響分析
• 流行病學
• 各國醫療費用支出
• 按國家/地區分類的疫苗接種覆蓋率
• 製造能力
• 經銷商狀況
• 投資金籌措
• 比賽簡介
• 熱圖分析

第4章2019-2031年全球IPV疫苗市場（以疫苗品牌）

• 介紹
• 脊髓灰質炎(PFS/SD)
• 沙尼普
• Orix
• IPOL/伊莫瓦克斯
• 聚滅蟻靈

第5章2019-2031年全球IPV疫苗市場（依疫苗類型）

• 介紹
• 聯合疫苗
• 單一疫苗

第6章全球IPV 疫苗市場，以管瓶型分類，2019-2031 年

• 介紹
• 單劑量管瓶
• 5 劑管瓶
• 10 劑管瓶

第7章2019-2031年全球IPV疫苗市場（依通路）

• 介紹
• 公共
• 私人的

第8章2019-2031年全球IPV疫苗市場（按地區）

• 介紹
• 北美洲
• 美國
• 加拿大
• 歐洲
• 英國
• 德國
• 義大利
• 法國
• 西班牙
• 俄羅斯
• 歐洲其他地區
• 亞太地區
• 中國
• 印度
• 日本
• 澳洲
• 韓國
• 東南亞國協
• 其他亞太地區
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 中東
• 波灣合作理事會
• 以色列
• 其他中東地區
• 非洲
• 南非
• 北非
• 中部非洲

第9章 競爭格局

第10章公司簡介-全球IPV疫苗市場

• Sanofi
• 最新動態/更新
• Serum Institute of India Pvt. Ltd.
• Bharat Biotech
• Merck &Co., Inc.
• GlaxoSmithKline
• AJ Vaccines A/S
• Panacea Biotec
• Biken
• Sinopharm Group Co. Ltd.
• Nanolek
• IMBCAMS
• Sinovac Biotech
• LG Chem
• Beijing Minhai Biological Technology Co., Ltd.
• Biological E Limited.
• 升起和降落
• 分析師觀點
• 綜合機會圖

第11章 參考文獻與調查方法

• 參考
• 調查方法

The global IPV vaccines market is estimated to be valued at USD 199.6 Mn in 2024 and is expected to exhibit a CAGR of 8.5% during the forecast period (2024-2031).

Global IPV Vaccines Market Value (USD Mn), by Region, 2024

Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. The IPV vaccine is mostly given in arm or leg as a shot.

Individuals who are allergic to eggs or the drugs such as streptomycin should not receive the injectable IPV. The IPV is only given if the vaccine recipient is on steroid therapy for long-term, has cancer, or is on ongoing process of chemotherapy or there is any unimmunized adult in house.

Global IPV vaccines market was valued at USD 199.6 Mn in 2024 and is expected to increase to US$ 352.4 Mn by 2031, registering a CAGR of 8.5% over the forecast period.

Market Dynamics

Various governments have taken initiatives to increase awareness regarding vaccination to prevent occurrence of polio among the population. Public introduced beneficial immunization programs to provide vaccination to poor people, which is expected to create a highly conducive environment for growth of the Global Inactivated Polio Vaccines Market (IPV) in the near future. For instance, in September 2019, the Ghana Health Service (GHS), launched series of polio vaccination/immunization campaign to prevent spreading of the virus in high risk areas. The immunization polio vaccination campaign will use the inactivated polio vaccine (IPV) to immunize all the children born from January 2016 to June 2018 in all districts across Ghana.

Key features of the study:

• This report provides in-depth analysis of the Global IPV vaccines market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Global IPV vaccines market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include GlaxoSmithKline Plc, Sanofi S.A., Serum Institute of India Pvt. Ltd., PT Bio Farma, and AJ Vaccines
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The IPV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global IPV vaccines market

Detailed Segmentation:

• Global IPV Vaccines Market, by Vaccine Brand:
  • Poliovac (Pfs/Sd)
  • Shanipv
  • Poliorix
  • Ipol/Imovax
  • Polymilex
• Global IPV Vaccines Market, by Distribution Channel:
  • Private
  • Public
• Global IPV Vaccines Market, by Region:
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles:
  • GlaxoSmithKline Plc
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • PT Bio Farma
  • AJ Vaccines

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Vaccine Brand
  • Market Snapshot, By Vaccine Type
  • Market Snapshot, By Vial Type
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
  • Market Scenario - Conservative, Likely, Opportunistic
• Market Opportunity Map

3. Key Insights

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Pest Analysis
• Porters Analysis
• Company Market Share Analysis
• Import-Export Analysis
• Regulatory Scenario
• Pricing Analysis
• COVID-19 Impact Analysis
• Epidemiology
• Healthcare Spending, by Country
• Vaccination Rate, by Country
• Manufacturing Capacities
• Distributors Landscape
• Investments & Funding
• Competitive Snapshot
• Heat Map Analysis

4. Global IPV Vaccines Market, By Vaccine Brand, 2019 - 2031 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2024, 2027 & 2031
  • Market Y-o-Y Growth Comparison (%), 2019 - 2031
  • Segment Trends
• POLIOVAC (PFS/SD), 2019 - 2031(US$ Million)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Million)
• SHANIPV, 2019 - 2031(US$ Million)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Million)
• POLIORIX, 2019 - 2031(US$ Million)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Million)
• IPOL/IMOVAX, 2019 - 2031(US$ Million)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Million)
• POLYMILEX, 2019 - 2031(US$ Million)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Million)

5. Global IPV Vaccines Market, By Vaccine Type, 2019 - 2031 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2024, 2027 & 2031
  • Market Y-o-Y Growth Comparison (%), 2019 - 2031
  • Segment Trends
• Combination Vaccine, 2019 - 2031(US$ Million)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Million)
• Single Vaccine, 2019 - 2031(US$ Million)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Million)

6. Global IPV Vaccines Market, By Vial Type, 2019 - 2031 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2024, 2027 & 2031
  • Market Y-o-Y Growth Comparison (%), 2019 - 2031
  • Segment Trends
• 1 Dose Vial, 2019 - 2031(US$ Million)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Million)
• 5 Dose Vial, 2019 - 2031(US$ Million)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Million)
• 10 Dose Vial, 2019 - 2031(US$ Million)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Million)

7. Global IPV Vaccines Market, By Distribution Channel, 2019 - 2031 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2024, 2027 & 2031
  • Market Y-o-Y Growth Comparison (%), 2019 - 2031
  • Segment Trends
• Public, 2019 - 2031(US$ Million)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Million)
• Private, 2019 - 2031(US$ Million)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Million)

8. Global IPV Vaccines Market, By Region, 2019 - 2031 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Million)
  • Market Y-o-Y Growth Comparison (%), 2024 - 2031, (US$ Million)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Country, 2019 - 2031, (US$ Million)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Country, 2019 - 2031, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest Of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Country, 2019 - 2031, (US$ Million)
• China
• India
• Japan
• Australia
• South Korea
• Asean
• Rest Of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Country, 2019 - 2031, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Country, 2019 - 2031, (US$ Million)
• GCC
• Israel
• Rest Of The Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Million)
  • Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Million)
• South Africa
• North Africa
• Central Africa

9. Competitive Landscape

• Competitive Snapshot
• What Market Participants are Saying?
• Competitive Dashboard
• Company Market Share Analysis, 2024 - Global

10. Company Profiles - Global IPV Vaccines Market

• Sanofi*
  • Company Overview
  • Product/Service Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategic Overview
• Serum Institute of India Pvt. Ltd.
• Bharat Biotech
• Merck & Co., Inc.
• GlaxoSmithKline
• AJ Vaccines A/S
• Panacea Biotec
• Biken
• Sinopharm Group Co. Ltd.
• Nanolek
• IMBCAMS
• Sinovac Biotech
• LG Chem
• Beijing Minhai Biological Technology Co., Ltd.
• Biological E Limited.
• Section 10: Wheel of Fortune
• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact